FindMyRecallSubscribe
Class I: serious health riskTerminated

Hospira Bupivacaine Hydrochloride Inj Recall

Bupivacaine Hydrochloride Inj

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Jul 15, 2015
Recall ID
D-1216-2015
Check your lot numberHow we source this data

Summary

Hospira recalled Bupivacaine Hydrochloride Inj starting Apr 23, 2015. The FDA classified it as Class I (serious health risk) and published enforcement report D-1216-2015 on Jul 15, 2015. Reason: Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Product description

Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.

Lot numbers, UPCs & expiration codes

Lot #: 38-515-DK, Expiry: 1 FEB 2016.

Where it was sold

U.S. Nationwide including Guam.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1216-2015
Classification
Class I
Status
Terminated
Recall initiated
Apr 23, 2015
FDA report date
Jul 15, 2015
Quantity
150,950 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-1216-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
71377
Address
600 N Field Dr
Code information
Lot #: 38-515-DK, Expiry: 1 FEB 2016.
Postal code
60045-4835
Report date
Jul 15, 2015
Product type
Drugs
Recall number
D-1216-2015
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
150,950 Vials
Termination date
Jan 26, 2016
Reason for recall
Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC., LAKE FOREST, IL 60045 USA. NDC: 0409-1162-02.
Distribution pattern
U.S. Nationwide including Guam.
Recall initiation date
Apr 23, 2015
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jul 8, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1216-2015, published Jul 15, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls